Hanmi Pharmaceuticals Signs an Exclusive License Agreement with Janssen to Develop Treatment for Diabetes, Obesity

By: via Benzinga
Hanmi Pharmaceuticals Co., Ltd. today announced that it has entered into an exclusive license, agreement with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.